Homer-Dixon on Canada’s vaccine rollout

Complexity researcher Dr. Thomas Homer-Dixon, director of the Cascade Institute at Royal Roads University, joined host Charles Adler on Charles Adler Tonight to hash out Canada’s vaccine rollout and recent media coverage.

Here’s an excerpt:

“I think what we’re likely to see with these new variants is that the response will have to extend well into 2022 or 2023. We are dealing with something that will most likely become chronic. We’re going to have to adjust our vaccines in response to our knowledge of the variants pretty much on the fly… it may turn out that by 2022, having this vaccine production capacity in Canada is very important. But the Globe and Mail is right, in response to the current situation this doesn’t help us much, because we want to get as many shots into people’s arms as possible in the next month.

[…]

“We’re in for the long haul, here. And this is the first of what will likely be more pandemics. We’ve created circumstances on the planet where these situations are pretty likely. We’ve learned a tough lesson here… what we’ve learned is our branch plant economy has not prepared us well for this kind of crisis. And we need more domestic capacity in lots of areas.”

Listen to the full interview at the 17:28 time mark on the Charles Adler Tonight podcast.